What sets our approach apart is our commitment to long-term follow-up. Every patient receives annual questionnaires following their sclerotherapy, providing us with robust, long-term data. As far as I’m aware, no other centres are collecting this level of comprehensive follow-up data.
While short- and medium-term results have earned laser therapy its reputation as a gold standard, long-term outcome data remains limited in other clinics. In contrast, our data collection at Southwest Veins offers a clearer picture of sustained treatment success.
When you consider that:
- Foam sclerotherapy is better tolerated by patients,
- It’s less painful,
- Quicker and easier to perform,
- And significantly more cost-effective –
…it’s clear why foam sclerotherapy should be the primary treatment modality for varicose veins.
Jamie Barwell is a Consultant Vascular Surgeon who has treated over 1000 patients with varicose vein problems, using open surgical techniques and, since 2007, foam sclerotherapy. He is a graduate of Guy’s Hospital Medical School and a fellow of Royal College of Surgeons of England.